PTC Therapeutics (PTCT) PT Lowered to $76 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad lowered the price target on PTC Therapeutics (NASDAQ: PTCT) to $76.00 (from $82.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
